Efficacy and Safety of Bevacizumab (Avastin) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours
Trial Number
NCT01770301 (ClinicalTrials.gov Identifier)Contact Person
Status
Completed
Disease Site
Ovarian/Rare
Lead Cooperative Group
Participating Groups
MITO
BGOG
AGO
GOTIC